Stephen Mandel - Lone Pine Capital
Holding/activity history for Ascendis Pharma A/S (ASND)
← All ASND superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2021 Q4 | 0 | 0.00 | Sell 100.00% | 0.77 | $125.00–172.65 · VW $145.27i | SEC | |
| 2021 Q3 | 1,436,981 | 0.77 | $159.39 | $229,040,000 | SEC | ||
| 2021 Q2 | 1,436,981 | 0.61 | $131.55 | $189,035,000 | SEC | ||
| 2021 Q1 | 1,436,981 | 0.67 | Add 60.64% | 0.25 | $121.68–177.60 · VW $148.19i | $185,198,000 | SEC |
| 2020 Q4 | 894,533 | 0.54 | Buy | 0.54 | $150.40–183.98 · VW $166.79i | $149,190,000 | SEC |
Price snapshot:
Current price$265.22
52-week low$160.86
52-week high$282.15